What I want to see is actual results. I would
Post# of 36537
(Total Views: 282)
Posted On: 12/03/2020 7:04:28 PM
What I want to see is actual results.
I would like an honest break down on timelines for a change. We have heard since November of last year on an NGIO listing as well as how straight forward it should be. This last time, it was about revenue for the S-1. That should be done and there should not be any reason that information has not been put in, since the deals have been done.
So, no reason for the S-1 not being approved now. So, no reason for the listing not to go forward then when that happens (soon).
So, we should have an appraisal as well I would think. I can't think of any reason why that should not be completed either.
So, I don't see why they should not have the results of the Peptide testing by now. It's been way to long on those and by now, they should be completed.
I don't care how good Joe says this vaccine can be, if the giants are way ahead and NGIO vaccine is going to be months and months from now, then Joe better start marketing now for investors and show some results on something because the giants and their information, their marketing machines are going to eat him alive. Joe is holding his information on the peptides weeks and weeks late and it is hurting the company and the shareholders and he needs to stop it. For a marketing guy, I am really questioning his thought process on this.
He needs to start really showing results. Another year is coming and we are still waiting. I know some on here keep saying patience, patience, patience. That's been going on for over a year now.
Companies need to start producing at some point. Deals are good. Information and results are better.
Sitting at .20 - 22 is getting old for GNBT and with NGIO still with no value and nothing yet on the horizon currently on when the listing takes place, .20 -22 looks to be the norm for a while.
I would like an honest break down on timelines for a change. We have heard since November of last year on an NGIO listing as well as how straight forward it should be. This last time, it was about revenue for the S-1. That should be done and there should not be any reason that information has not been put in, since the deals have been done.
So, no reason for the S-1 not being approved now. So, no reason for the listing not to go forward then when that happens (soon).
So, we should have an appraisal as well I would think. I can't think of any reason why that should not be completed either.
So, I don't see why they should not have the results of the Peptide testing by now. It's been way to long on those and by now, they should be completed.
I don't care how good Joe says this vaccine can be, if the giants are way ahead and NGIO vaccine is going to be months and months from now, then Joe better start marketing now for investors and show some results on something because the giants and their information, their marketing machines are going to eat him alive. Joe is holding his information on the peptides weeks and weeks late and it is hurting the company and the shareholders and he needs to stop it. For a marketing guy, I am really questioning his thought process on this.
He needs to start really showing results. Another year is coming and we are still waiting. I know some on here keep saying patience, patience, patience. That's been going on for over a year now.
Companies need to start producing at some point. Deals are good. Information and results are better.
Sitting at .20 - 22 is getting old for GNBT and with NGIO still with no value and nothing yet on the horizon currently on when the listing takes place, .20 -22 looks to be the norm for a while.
(4)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼